Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

The OVAL Study: A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer (VB-111-701 / GOG-3018)

  • Details

ClinicalTrials.gov ID: NCT03398655
Diagnosis Type: NA
USOR Number: 17189

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Scottsdale

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

10197 N 92nd St, Suite 101
Scottsdale, Arizona 85258
55.54 mi. away
P: (480) 993-2950

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

The OVAL Study: A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer (VB-111-701 / GOG-3018)

  • Details

ClinicalTrials.gov ID: NCT03398655
Diagnosis Type: NA
USOR Number: 17189

  • Practice Details

19646 N 27th Avenue, Suite 406
Phoenix, Arizona 85027
64.43 mi. away
P: (602) 357-2400

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

The OVAL Study: A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer (VB-111-701 / GOG-3018)

  • Details

ClinicalTrials.gov ID: NCT03398655
Diagnosis Type: NA
USOR Number: 17189

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Phoenix

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

2222 E Highland Ave, Suite 400
Phoenix, Arizona 85016
65.69 mi. away
P: (602) 277-4868

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

1845 W Orange Grove, Bldg 2
Tucson, Arizona 85704
119.32 mi. away
P: (520) 531-8967

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

2070 W Rudasill Rd, Suite 130
Tucson, Arizona 85704
119.74 mi. away
P: (520) 797-4468

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)

  • Details

ClinicalTrials.gov ID: NCT03319628
Diagnosis Type: NA
USOR Number: 19081

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number: 17206

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Arizona Oncology - Tucson

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, Arizona 85711
126.35 mi. away
P: (520) 886-0206

More Details View Practice Page

Pages